Diastolic Heart Failure Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Diastolic Heart Failure Clinical Trials Market Report Overview
There were a total of 322 diastolic heart failure clinical trials conducted as of April 2022. The diastolic heart failure clinical trial market research report provides a comprehensive overview of the market across regions and countries (G7 & E7). It also provides insights into the various phases, trial status, and end points status. The report includes information about the sponsor types and the prominent sponsors associated with the trials as well.
Diastolic Heart Failure Clinical Trials Market Segmentation by Regions
The key regions where diastolic heart failure clinical trials are conducted are North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America. As of April 2022, North America accounted for the highest share of the regional landscape. Sponsors conducted more than 30% of the trials in this region.
Diastolic Heart Failure Clinical Trials Analysis by Regions, 2022 (%)
Buy the Full Report for More Regional Insights into the Diastolic Heart Failure Clinical Trials Market
Key Regions | · North America
· Europe · Asia-Pacific · Middle East & Africa · South & Central America |
Key Countries | · The US
· Germany · Japan · China · The UK |
Leading Sponsors | · AstraZeneca Plc
· Novartis AG · Bayer AG · C. H. Boehringer Sohn AG & Co KG · Eli Lilly and Co |
Key Sponsor Types | · Company
· Institution · Government |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Diastolic Heart Failure Clinical Trials Market Segmentation by Countries
- Country Insights
The US had the highest number of diastolic heart failure clinical trials, as of April 2022. Meanwhile, the Netherlands had the highest average patient enrollment as of April 2022.
- G7 Countries
Among the G7 (US, UK, Germany, France, Italy, Canada, and Japan) countries, the US had the highest proportion of diastolic heart failure in cardiovascular clinical trials as of April 2022.
- E7 countries
Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Mexico had the highest proportion of diastolic heart failure in cardiovascular clinical trials as of April 2022.
Diastolic Heart Failure Clinical Trials Analysis by Countries, 2022 (%)
Buy the Full Report for More Country Insights into the Diastolic Heart Failure Clinical Trials Market
Diastolic Heart Failure Clinical Trials Market - Competitive Landscape
A few of the leading sponsors associated with the market are:
- AstraZeneca Plc
- Novartis AG
- Bayer AG
- H. Boehringer Sohn AG & Co KG
- Eli Lilly and Co
AstraZeneca Plc conducted the highest number of diastolic heart failure clinical trials in 2022.
Diastolic Heart Failure Clinical Trials Market Analysis by Sponsors, 2022 (%)
Buy the Full Report for More Sponsor Insights into the Diastolic Heart Failure Clinical Trials Market
Diastolic Heart Failure Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the market are companies, institutions, and the government. Out of them, the institution segment dominated the market in April 2022.
Diastolic Heart Failure Clinical Trials Market Analysis by Sponsor Types, 2022 (%)
Buy the Full Report for More Sponsor Type Insights into the Diastolic Heart Failure Clinical Trials Market
Segments Covered in the Report
Diastolic Heart Failure Clinical Trials Regional Outlook (2022)
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South and Central America
Diastolic Heart Failure Clinical Trials Country Outlook (2022)
- The US
- Germany
- Japan
- China
- The UK
Diastolic Heart Failure Clinical Trials Regional Outlook (2022)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and end-point status.
- The report reviews the top companies involved and enlists all trials about the company.
- The report provides all the unaccomplished trials with reasons for unaccomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Assists in formulating key business strategies about investment.
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost.
- Provides top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities.
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market.
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted trials.
Novartis AG
Bayer AG
C. H. Boehringer Sohn AG & Co KG
Eli Lilly and Co
Johnson & Johnson
Abbott Laboratories
Cyclerion Therapeutics Inc
Gilead Sciences Inc
Pamplona Capital Management LLP
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of diastolic heart failure clinical trials in April 2022?
North America accounted for the highest number of diastolic heart failure clinical trials as of April 2022.
-
Which country conducted the highest number of diastolic heart failure clinical trials in April 2022?
The US conducted the highest number of diastolic heart failure clinical trials as of April 2022.
-
Which sponsor type was the most prominent in the diastolic heart failure clinical trials in April 2022?
As of April 2022, the institution sponsor type conducted most of the diastolic heart failure clinical trials.
-
Which are the leading sponsors of diastolic heart failure clinical trials?
A few of the leading sponsors of diastolic heart failure clinical trials are AstraZeneca Plc, Novartis AG, Bayer AG, C. H. Boehringer Sohn AG & Co KG, and Eli Lilly and Co, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.